Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Roche Launches New Cyclospora PCR Tests Amid US Outbreak

6 August 2026 · By · Wire by Fusion42

Published

6 August 2026

Topic

opportunities

◆ Sectors

Diagnostics

◆ Geography

United States

◆ Source

Read at clpmag.com →

◆ Verified

Fusion42 · 7 August 2026 · Fusion42 review

Roche, through its subsidiary TIB MOLBIOL, launched two new research PCR tests targeting the Cyclospora parasite amid a growing outbreak in the United States, aiming to help labs respond rapidly to public health needs with flexible testing options.

This Wire brief sits within Fusion42's coverage of Diagnostics.

◆ ◆ The Wire takeaway

Your diagnostics startup must now factor in emerging parasite testing on multipurpose PCR platforms where Roche just raised the bar. Labs adopting Roche's flexible panel tests open doors for you to integrate or compete in gastrointestinal pathogen detection.

◆ Coverage

1 source · 6 Aug 2026

◆ Related on Wire

◆ Topics

Diagnosticsrochecyclosporapcr-testinginfectious-diseaseus-outbreak